Theriva Biologics Announces Pricing of $7.5 Million Public Offering - Stock Titan
12 hours ago • Google News
Theriva Biologics Inc. (TOVX)
US$ 1.42090.55%
Price Chart
Key Statistics
Market Cap
$ 3.84M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
41.12K
52W High
$ 12.25
52W Low
$ 0.96
Dividend Yield
0.00%
Beta
1.17
Technicals
50-Day MA
1.2836
200-Day MA
2.2498
52 Week High
12.25
52 Week Low
0.96
About TOVX
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
Employees
20
Headquarters
Rockville, MD
CEO
Mr. Steven A. Shallcross CPA
Latest News
Theriva Biologics Announces Pricing of $7.5 Million Public Offering - GlobeNewswire
12 hours ago • Google News
Theriva Biologics (TOVX) Announces $7.5 Million Public Offering - GuruFocus
11 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg